CoRISMA Cardiovascular is a medical device company developing a heart failure system to treat patients suffering from advanced heart failure.
CoRISMA, spun out of the Bonde Artificial Heart Lab at Yale University, is positioned to disrupt the existing market. CoRISMA is a fully implanted transcatheter device that is wirelessly powered with our world renowned energy transmission technology.
Our team is devoted to developing this transformative device for the countless advanced heart failure patients and their clinicians seeking alternatives to existing treatments. We are further motivated to dramatically reduce the tremendous economic burden each country faces treating heart failure.